{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:35:16Z","timestamp":1786980916173,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T00:00:00Z","timestamp":1475884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T00:00:00Z","timestamp":1475884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP0199"],"award-info":[{"award-number":["PIP0199"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT 01\/W373"],"award-info":[{"award-number":["UBACYT 01\/W373"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10637-016-0397-9","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T22:07:19Z","timestamp":1475878039000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines"],"prefix":"10.1007","volume":"35","author":[{"given":"Silvina Laura","family":"Lompard\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1ngeles","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Laura","family":"Papademetrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Pibuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lida","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Elvira","family":"Hajos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,8]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3238\/arztebl.2010.0114","volume":"107","author":"N von Bubnoff","year":"2010","unstructured":"von Bubnoff N, Duyster J (2010) Chronic myelogenous leukemia. Dtsch Arztebl Int 107:114\u2013121. doi:10.3238\/arztebl.2010.0114","journal-title":"Dtsch Arztebl Int"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1756-8722-3-47","volume":"3","author":"G Wei","year":"2010","unstructured":"Wei G, Rafiyath S, Liu D (2010) First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J Hematol Oncol 3:47. doi:10.1186\/1756-8722-3-47","journal-title":"J Hematol Oncol"},{"key":"397_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cancergen.2011.03.002","volume":"204","author":"HS Chandraa","year":"2011","unstructured":"Chandraa HS, Heistekampb NC, Hungerfordc A et al (2011) Philadelphia chromosome symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome. Cancer Genet 204:171\u2013179. doi:10.1016\/j.biotechadv.2011.08.021.Secreted","journal-title":"Cancer Genet"},{"key":"397_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.exphem.2013.11.006","volume":"42","author":"EG Karimiani","year":"2014","unstructured":"Karimiani EG, Marriage F, Merritt AJ et al (2014) Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Exp Hematol 42:183\u2013191. doi:10.1016\/j.exphem.2013.11.006","journal-title":"Exp Hematol"},{"key":"397_CR5","doi-asserted-by":"publisher","unstructured":"Wetzel R, Goss VL, Norris B et al (2005) Evaluation of CML model cell lines and imatinib mesylate response: determinants of signaling profiles. J Immunol Methods 305:59\u201366. doi:10.1016\/j.jim.2005.07.012","DOI":"10.1016\/j.jim.2005.07.012"},{"key":"397_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.111","volume":"3","author":"C Drullion","year":"2012","unstructured":"Drullion C, Tr\u00e9goat C, Lagarde V et al (2012) Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis 3:e373. doi:10.1038\/cddis.2012.111","journal-title":"Cell Death Dis"},{"key":"397_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Vitale I, Abrams JM et al (2012) Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ 19:107\u2013120. doi:10.1038\/cdd.2011.96","journal-title":"Cell Death Differ"},{"key":"397_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi J, di d\u2019Adda FF (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729\u2013740. doi:10.1038\/nrm2233","journal-title":"Nat Rev Mol Cell Biol"},{"key":"397_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","volume":"192","author":"F Rodier","year":"2011","unstructured":"Rodier F, Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192:547\u2013556. doi:10.1083\/jcb.201009094","journal-title":"J Cell Biol"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrc3057","volume":"11","author":"C Nardella","year":"2011","unstructured":"Nardella C, Clohessy JG, Alimonti A, Pandolfi PP (2011) Pro-senescence therapy for cancer treatment. Nat Rev Cancer 11:503\u2013511. doi:10.1038\/nrc3057","journal-title":"Nat Rev Cancer"},{"key":"397_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"J Campisi","year":"2013","unstructured":"Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685\u2013705. doi:10.1146\/annurev-physiol-030212-183653","journal-title":"Annu Rev Physiol"},{"key":"397_CR12","first-page":"191","volume":"3","author":"M Comert","year":"2013","unstructured":"Comert M, Baran Y, Saydam G (2013) Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era. Am J Blood Res 3:191\u2013200","journal-title":"Am J Blood Res"},{"key":"397_CR13","doi-asserted-by":"publisher","unstructured":"Mauro MJ (2006) Defining and managing imatinib resistance. Hematology Am Soc Hematol Educ Program:219\u2013225. doi:10.1182\/asheducation-2006.1.219","DOI":"10.1182\/asheducation-2006.1.219"},{"key":"397_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissel","year":"2001","unstructured":"Bissel MJ, Radisky D (2001) Putting tumors in context. Nat Rev Cancer 1:46\u201354. doi:10.1038\/35094059.PUTTING","journal-title":"Nat Rev Cancer"},{"key":"397_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/bjc.2012.592","volume":"108","author":"GS Wong","year":"2013","unstructured":"Wong GS, Rustgi a K (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer 108:755\u2013761. doi:10.1038\/bjc.2012.592","journal-title":"Br J Cancer"},{"key":"397_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"397_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800092-2.09991-3","author":"M Simpson","year":"2014","unstructured":"Simpson M, Heldin P (2014) Hyaluronan signaling and turnover. Books. doi:10.1016\/B978-0-12-800092-2.09991-3","journal-title":"Books"},{"key":"397_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528\u2013539. doi:10.1038\/nrc1391","journal-title":"Nat Rev Cancer"},{"key":"397_CR19","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.bbagen.2014.02.001","volume":"1840","author":"D Vigetti","year":"2014","unstructured":"Vigetti D, Karousou E, Viola M et al (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta - Gen Subj 1840:2452\u20132459. doi:10.1016\/j.bbagen.2014.02.001","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"397_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2014.01.014","volume":"35","author":"VC Hascall","year":"2014","unstructured":"Hascall VC, Wang A, Tammi M et al (2014) The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol 35:14\u201317. doi:10.1016\/j.matbio.2014.01.014","journal-title":"Matrix Biol"},{"key":"397_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/glycob\/cws218","volume":"23","author":"AB Csoka","year":"2013","unstructured":"Csoka AB, Stern R (2013) Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology 23:398\u2013411. doi:10.1093\/glycob\/cws218","journal-title":"Glycobiology"},{"key":"397_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/glycob\/cwt074","volume":"23","author":"SL Lompard\u00eda","year":"2013","unstructured":"Lompard\u00eda SL, Papademetrio DL, Mascar\u00f3 M et al (2013) Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy. Glycobiology 23:1463\u20131476","journal-title":"Glycobiology"},{"key":"397_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.yexcr.2010.11.017","volume":"317","author":"RK Sironen","year":"2011","unstructured":"Sironen RK, Tammi M, Tammi R et al (2011) Hyaluronan in human malignancies. Exp Cell Res 317:383\u2013391. doi:10.1016\/j.yexcr.2010.11.017","journal-title":"Exp Cell Res"},{"key":"397_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/ijc.27707","volume":"132","author":"P Auvinen","year":"2013","unstructured":"Auvinen P, Tammi R, Kosma VM et al (2013) Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Int J Cancer 132:531\u2013539. doi:10.1002\/ijc.27707","journal-title":"Int J Cancer"},{"key":"397_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1477-3163-5-2","volume":"5","author":"RK Boregowda","year":"2006","unstructured":"Boregowda RK, Appaiah HN, Siddaiah M et al (2006) Expression of hyaluronan in human tumor progression. J Carcinog 5:2. doi:10.1186\/1477-3163-5-2","journal-title":"J Carcinog"},{"key":"397_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2012.569","volume":"108","author":"PP Provenzano","year":"2013","unstructured":"Provenzano PP, Hingorani SR (2013) Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer 108:1\u20138. doi:10.1038\/bjc.2012.569","journal-title":"Br J Cancer"},{"key":"397_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","volume":"18","author":"RH Tammi","year":"2008","unstructured":"Tammi RH, Kultti A, Kosma VM et al (2008) Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 18:288\u2013295. doi:10.1016\/j.semcancer.2008.03.005","journal-title":"Semin Cancer Biol"},{"key":"397_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/onc.2011.222","volume":"31","author":"LYW Bourguignon","year":"2012","unstructured":"Bourguignon LYW, Earle C, Wong G, Spevak CC (2012) Stem cell marker (Nanog) and stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan\/ CD44-activated head and neck squamous cell carcinoma cells. Oncogene 31:149\u2013160. doi:10.1038\/onc.2011.222.Stem","journal-title":"Oncogene"},{"key":"397_CR29","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole BP (2009) Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 15:7462\u20137468. doi:10.1158\/1078-0432.CCR-09-0479.Hyaluronan-CD44","journal-title":"Clin Cancer Res"},{"key":"397_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jb\/mvt085","volume":"154","author":"P Heldin","year":"2013","unstructured":"Heldin P, Basu K, Olofsson B et al (2013) Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. J Biochem 154:395\u2013408. doi:10.1093\/jb\/mvt085","journal-title":"J Biochem"},{"key":"397_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","volume":"6","author":"S Misra","year":"2015","unstructured":"Misra S, Hascall VC, Markwald RR et al (2015) Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 6:201. doi:10.3389\/fimmu.2015.00201","journal-title":"Front Immunol"},{"key":"397_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/glycob\/cwv107","volume":"26","author":"SL Lompard\u00eda","year":"2016","unstructured":"Lompard\u00eda SL, D\u00edaz M, Papademetrio DL et al (2016) Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of imatinib. Glycobiology 26:343\u2013352","journal-title":"Glycobiology"},{"key":"397_CR33","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.yexcr.2009.03.002","volume":"315","author":"A Kultti","year":"2009","unstructured":"Kultti A, Pasonen-Sepp\u00e4nen S, Jauhiainen M et al (2009) 4-methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315:1914\u20131923. doi:10.1016\/j.yexcr.2009.03.002","journal-title":"Exp Cell Res"},{"key":"397_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2015.00123","volume":"6","author":"N Nagy","year":"2015","unstructured":"Nagy N, Kuipers HF, Frymoyer AR et al (2015) 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 6:123. doi:10.3389\/fimmu.2015.00123","journal-title":"Front Immunol"},{"key":"397_CR35","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/bjc.2011.459","volume":"105","author":"E Arai","year":"2011","unstructured":"Arai E, Nishida Y, Wasa J et al (2011) Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo. Br J Cancer 105:1839\u20131849. doi:10.1038\/bjc.2011.459","journal-title":"Br J Cancer"},{"key":"397_CR36","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1158\/0008-5472.CAN-09-3185","volume":"70","author":"VB Lokeshwar","year":"2010","unstructured":"Lokeshwar VB, Lopez LE, Munoz D et al (2010) Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res 70:2613\u20132623. doi:10.1158\/0008-5472.CAN-09-3185","journal-title":"Cancer Res"},{"key":"397_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/glycob\/cwr158","volume":"22","author":"F Piccioni","year":"2012","unstructured":"Piccioni F, Malvicini M, Garcia MG et al (2012) Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology 22:400\u2013410. doi:10.1093\/glycob\/cwr158","journal-title":"Glycobiology"},{"key":"397_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ijc.26014","volume":"130","author":"H Urakawa","year":"2012","unstructured":"Urakawa H, Nishida Y, Wasa J et al (2012) Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Int J Cancer 130:454\u2013466. doi:10.1002\/ijc.26014","journal-title":"Int J Cancer"},{"key":"397_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1476-4598-10-30","volume":"10","author":"S Twarock","year":"2011","unstructured":"Twarock S, Freudenberger T, Poscher E et al (2011) Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer 10:30. doi:10.1186\/1476-4598-10-30","journal-title":"Mol Cancer"},{"key":"397_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11523-013-0278-5","volume":"9","author":"DL Papademetrio","year":"2014","unstructured":"Papademetrio DL, Cavaliere V, Simunovich T et al (2014) Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine. Target Oncol 9:123\u2013134. doi:10.1007\/s11523-013-0278-5","journal-title":"Target Oncol"},{"key":"397_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1593\/tlo.08202","volume":"2","author":"V Cavaliere","year":"2009","unstructured":"Cavaliere V, Papademetrio DL, Lorenzetti M et al (2009) Caffeic acid Phenylethyl Ester and MG-132 have apoptotic and Antiproliferative effects on leukemic cells but not on normal mononuclear cells. Transl Oncol 2:46\u201358. doi:10.1593\/tlo.08202","journal-title":"Transl Oncol"},{"key":"397_CR42","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4:1798\u20131806. doi:10.1038\/nprot.2009.191","journal-title":"Nat Protoc"},{"key":"397_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037205","author":"MY Yang","year":"2012","unstructured":"Yang MY, Lin PM, Liu YC et al (2012) Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells. PLoS One. doi:10.1371\/journal.pone.0037205","journal-title":"PLoS One"},{"key":"397_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11523-015-0388-3","volume":"11","author":"DL Papademetrio","year":"2016","unstructured":"Papademetrio DL, Lompard\u00eda SL, Simunovich T et al (2016) Inhibition of survival pathways MAPK and NF-kB triggers apoptosis in pancreatic ductal adenocarcinoma cells via suppression of autophagy. Target Oncol 11:183\u2013195. doi:10.1007\/s11523-015-0388-3","journal-title":"Target Oncol"},{"key":"397_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/1471-2407-14-435","volume":"14","author":"L Elfineh","year":"2014","unstructured":"Elfineh L, Classon C, Asplund A et al (2014) Tyrosine phosphorylation profiling via in situ proximity ligation assay. BMC Cancer 14:435. doi:10.1186\/1471-2407-14-435","journal-title":"BMC Cancer"},{"key":"397_CR46","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1182\/blood-2004-04-1433","volume":"104","author":"T Yin","year":"2004","unstructured":"Yin T, Wu YL, Sun HP et al (2004) Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood 104:4219\u20134225. doi:10.1182\/blood-2004-04-1433","journal-title":"Blood"},{"key":"397_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4149\/neo_2009_03_202","volume":"56","author":"K Czyzewski","year":"2009","unstructured":"Czyzewski K, Styczynski J (2009) Imatinib is a substrate for various multidrug resistance proteins. Neoplasma 56:202\u2013207. doi:10.4149\/neo","journal-title":"Neoplasma"},{"key":"397_CR48","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.leukres.2013.06.014","volume":"37","author":"KL Silva","year":"2013","unstructured":"Silva KL, de Souza PS, Nestal de Moraes G et al (2013) XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells. Leuk Res 37:1350\u20131358. doi:10.1016\/j.leukres.2013.06.014","journal-title":"Leuk Res"},{"key":"397_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10637-008-9138-z","volume":"27","author":"RL Oostendorp","year":"2009","unstructured":"Oostendorp RL, Buckle T, Beijnen JH et al (2009) The effect of P-gp (Mdr1a\/1b), BCRP (Bcrp1) and P-gp\/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. Investig New Drugs 27:31\u201340. doi:10.1007\/s10637-008-9138-z","journal-title":"Investig New Drugs"},{"key":"397_CR50","doi-asserted-by":"publisher","first-page":"25419","DOI":"10.1074\/jbc.M112.376699","volume":"287","author":"V Goncharova","year":"2012","unstructured":"Goncharova V, Serobyan N, Iizuka S et al (2012) Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J Biol Chem 287:25419\u201325433. doi:10.1074\/jbc.M112.376699","journal-title":"J Biol Chem"},{"key":"397_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physrev.00052.2009","volume":"91","author":"D Jiang","year":"2011","unstructured":"Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91:221\u2013264. doi:10.1152\/physrev.00052.2009","journal-title":"Physiol Rev"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-016-0397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-016-0397-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-016-0397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:50Z","timestamp":1678492850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-016-0397-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s10637-016-0397-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,8]]},"assertion":[{"value":"3 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author SLL declares that she has no conflict of interest. Author MD declares that she has no conflict of interest. Author DLP declares that she has no conflict of interest. Author MP declares that he has no conflict of interest. Author EA declares that she has no conflict of interest. Author SEH declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was supported by Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (PIP N\u00b00199 to SH); and Universidad de Buenos Aires (UBACYT B021 to SH), Argentina.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}